Skip to content

Clinical trials

Carcinoma, Transitional Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Clear all

618 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20032
20045
20055
20066
20076
200810
20093
201011
201111
201213
20136
201410
201518
201625
201748
201846
201960
202047
202150
202243
202347
202438
202546
202653

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed196
Recruiting132
Terminated90
Active, not recruiting76
Unknown status68
Not yet recruiting23
Withdrawn22
Enrolling by invitation4
Available3
Suspended2
Approved for marketing2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)23
M.D. Anderson Cancer Center14
Memorial Sloan Kettering Cancer Center11
Pfizer10
UroGen Pharma Ltd.10
National Taiwan University Hospital9
Bristol-Myers Squibb8
Fox Chase Cancer Center8
Hoffmann-La Roche8
Incyte Corporation8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell618
Urinary Bladder Neoplasms203
Carcinoma, Non-Small-Cell Lung116
Carcinoma, Renal Cell96
Melanoma81
Squamous Cell Carcinoma of Head and Neck68
Colorectal Neoplasms62
Neoplasm Metastasis56
Uterine Cervical Neoplasms56
Stomach Neoplasms55

Trials

Showing 26 to 50 of 618. Each trial links to its page on Pharma Observatory.

518 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.